tirzepatide hepatic impairment child-pugh Child–Turcotte–Pugh classification a to assess severity of chronic ◾ Evidence has shown that

Both are used in patients with polycystic ovarian syndrome and obesity

Biermann has heard from many GLP-1 users who want to stop the medication and is studying whether gradually spacing out doses such as moving from weekly injections to every other week can help maintain weight loss and other health benefits

They may also be considered in cases of insulin resistance, prediabetes, or other weight-related health concerns

Some Medicaid beneficiaries may have prescription drug coverage for Mounjaro, while others may be subject to prior authorization requirements, diagnosis restrictions, or additional clinical criteria